Patient Brochure

• Should Your Patient Be Tested
• Your Newly Diagnosed Patient
• Managing Your AAT Deficient Patient

Alpha₁-Antitrypsin (AAT) Deficiency: What it means and what you can do

This booklet is aimed at patients and families curious to learn more about AAT deficiency. This guide has information for everyone, including those considering testing, those recently diagnosed, and those just looking for more information on AAT deficiency.

The brochure covers the following topics:

• What is AAT deficiency?
• The screening and testing process
• What treatment might your doctor recommend?
• AAT augmentation with ARALAST [Alpha₁-Proteinase Inhibitor (Human)]
• Who you can contact for additional help
• Taking charge
• A helpful glossary of terms

You may order the Patient Brochure online or by phone at 1-866-ARALAST (272-5278).

You may also download a copy of the brochure.

ARALAST [Alpha₁-Proteinase Inhibitor (Human)] is indicated for chronic augmentation therapy in patients having congenital deficiency of A₁-PI with clinically evident emphysema. ARALAST is not indicated as therapy for lung disease patients in whom congenital A₁-PI deficiency has not been established.

Please review the Important Safety Information and the Full Prescribing Information